Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
- Conditions
- Hypercalcemia
- Registration Number
- NCT06467877
- Lead Sponsor
- University of Cologne
- Brief Summary
Patients with hypercalcemia were identified in the patient population of a German emergency department during a 11 year time period and studied regarding reproducibility of elevated calcium values, causes of hypercalcemia, symptoms. acute renal injury, mortality and treatment response.
- Detailed Description
Patients, who presented to the emergency department of a tertiary German hospital with a total calcium of ≥2.65 mmol/l between January 2010 and March 2021, was retrospectively studied. From the electronic patient records we analyzed if the elevated calcium values were reproducible in follow-up measurements, identified the cause of hypercalcemia, listed the symptoms, investigated a correlation between calcium and creatinine values to study acute renal injury directly due to hypercalcemia, calculated the mortality rate stratified by the calcium value on presentation and studied the treatment response regarding lowering calcium values by different treatments.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 200
- Age > 18 years
- Total calcium ≥ 2.65 mmol/l
- Female and male
- Age < 18 years
- Total calcium < 2.65 mmol/
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of total calcium values 5 days after enrollment Overview of total calcium values within 5 days
- Secondary Outcome Measures
Name Time Method Reproducibility of elevated calcium values 5 days after enrollment Determination of cause of hypercalcemia, of symptoms, of treatment response. In dependence of hospital stay, kann be determined later than 5 days after enrollment
Correlation creatinine calcium 5 days after enrollment Determination of correlation between calcium and creatinine.
Mortality 5 days after enrollment occurence of death within of 5 days after enrollment
Trial Locations
- Locations (1)
Department II of Internal Medicine,University of Cologne
🇩🇪Cologne, Germany